Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma: A review

Frederick N. Bebe, Shasa Hu, Tony L. Brown, Orien L. Tulp

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Increased incidence of comorbidity in advanced metastatic melanoma (AMM) is emerging as an important factor in patient prognosis, treatment, and survival. This paper reviews the impact of comorbidities on the prognosis and survival outcomes of patients diagnosed with AMM. Our search initially yielded limited results. We then broadened our search to include breast, colorectal, and prostate cancer and covered malignancies in which screening (like melanoma) is associated with the detection of early-stage disease. Most studies showed that a higher prevalence of comorbidity was associated with more advanced cancer stage. Both treatment and survival of patients were influenced by age and the extent of comorbidity. Racial differences in survival were greatest for patients with no comorbidities and less evident at higher levels of comorbidity. Comorbid conditions showed differential effects for prognosis, treatment, and survival. Limited information in the literature demonstrates that more research is warranted with respect to comorbidities and AMM.

Original languageEnglish (US)
Pages (from-to)16-23
Number of pages8
JournalJournal of Clinical and Aesthetic Dermatology
Volume12
Issue number1
StatePublished - Jan 1 2019

Fingerprint

Comorbidity
Melanoma
Survival
Early Diagnosis
Colorectal Neoplasms
Neoplasms
Prostatic Neoplasms
Therapeutics
Breast Neoplasms
Incidence
Research

Keywords

  • Advanced metastatic melanoma
  • Comorbidity
  • Prognosis
  • Race/ethnicity
  • Survival

ASJC Scopus subject areas

  • Dermatology

Cite this

Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma : A review. / Bebe, Frederick N.; Hu, Shasa; Brown, Tony L.; Tulp, Orien L.

In: Journal of Clinical and Aesthetic Dermatology, Vol. 12, No. 1, 01.01.2019, p. 16-23.

Research output: Contribution to journalReview article

@article{45416720050e4f729fa23bf6178eba41,
title = "Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma: A review",
abstract = "Increased incidence of comorbidity in advanced metastatic melanoma (AMM) is emerging as an important factor in patient prognosis, treatment, and survival. This paper reviews the impact of comorbidities on the prognosis and survival outcomes of patients diagnosed with AMM. Our search initially yielded limited results. We then broadened our search to include breast, colorectal, and prostate cancer and covered malignancies in which screening (like melanoma) is associated with the detection of early-stage disease. Most studies showed that a higher prevalence of comorbidity was associated with more advanced cancer stage. Both treatment and survival of patients were influenced by age and the extent of comorbidity. Racial differences in survival were greatest for patients with no comorbidities and less evident at higher levels of comorbidity. Comorbid conditions showed differential effects for prognosis, treatment, and survival. Limited information in the literature demonstrates that more research is warranted with respect to comorbidities and AMM.",
keywords = "Advanced metastatic melanoma, Comorbidity, Prognosis, Race/ethnicity, Survival",
author = "Bebe, {Frederick N.} and Shasa Hu and Brown, {Tony L.} and Tulp, {Orien L.}",
year = "2019",
month = "1",
day = "1",
language = "English (US)",
volume = "12",
pages = "16--23",
journal = "Journal of Clinical and Aesthetic Dermatology",
issn = "1941-2789",
publisher = "Matrix Medical Communications",
number = "1",

}

TY - JOUR

T1 - Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma

T2 - A review

AU - Bebe, Frederick N.

AU - Hu, Shasa

AU - Brown, Tony L.

AU - Tulp, Orien L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Increased incidence of comorbidity in advanced metastatic melanoma (AMM) is emerging as an important factor in patient prognosis, treatment, and survival. This paper reviews the impact of comorbidities on the prognosis and survival outcomes of patients diagnosed with AMM. Our search initially yielded limited results. We then broadened our search to include breast, colorectal, and prostate cancer and covered malignancies in which screening (like melanoma) is associated with the detection of early-stage disease. Most studies showed that a higher prevalence of comorbidity was associated with more advanced cancer stage. Both treatment and survival of patients were influenced by age and the extent of comorbidity. Racial differences in survival were greatest for patients with no comorbidities and less evident at higher levels of comorbidity. Comorbid conditions showed differential effects for prognosis, treatment, and survival. Limited information in the literature demonstrates that more research is warranted with respect to comorbidities and AMM.

AB - Increased incidence of comorbidity in advanced metastatic melanoma (AMM) is emerging as an important factor in patient prognosis, treatment, and survival. This paper reviews the impact of comorbidities on the prognosis and survival outcomes of patients diagnosed with AMM. Our search initially yielded limited results. We then broadened our search to include breast, colorectal, and prostate cancer and covered malignancies in which screening (like melanoma) is associated with the detection of early-stage disease. Most studies showed that a higher prevalence of comorbidity was associated with more advanced cancer stage. Both treatment and survival of patients were influenced by age and the extent of comorbidity. Racial differences in survival were greatest for patients with no comorbidities and less evident at higher levels of comorbidity. Comorbid conditions showed differential effects for prognosis, treatment, and survival. Limited information in the literature demonstrates that more research is warranted with respect to comorbidities and AMM.

KW - Advanced metastatic melanoma

KW - Comorbidity

KW - Prognosis

KW - Race/ethnicity

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85060614294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060614294&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:85060614294

VL - 12

SP - 16

EP - 23

JO - Journal of Clinical and Aesthetic Dermatology

JF - Journal of Clinical and Aesthetic Dermatology

SN - 1941-2789

IS - 1

ER -